Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice

OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83
Hauptverfasser: Chen, Xingjuan, Qian, Shaomin, Hoggatt, April, Tang, Hongying, Hacker, Timothy A, Obukhov, Alexander G, Herring, Paul B, Seye, Cheikh I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 83
container_issue 1
container_start_page 75
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 37
creator Chen, Xingjuan
Qian, Shaomin
Hoggatt, April
Tang, Hongying
Hacker, Timothy A
Obukhov, Alexander G
Herring, Paul B
Seye, Cheikh I
description OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis. APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.
doi_str_mv 10.1161/ATVBAHA.116.308561
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5268079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1841799142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</originalsourceid><addsrcrecordid>eNpVkc9u1DAQxiMEon_gBTggH7mk2E5iby5IYdlSpLas2ILEyXKcCWuYjYPtUPWAxDvwhjwJjnZBcPF4PD9_o5kvy54wesaYYM-bmw8vm4tmTs4KuqgEu5cds4qXeSkKcT_dqazzSpT8KDsJ4TOltOScPsyOuEx0WZXH2ffV0Lm4BbQayRIQf_34uRnB2N4a8goQonUDcT1Z84-cvAMDY3SerL3buQiBrFF_nYBsom4t2nhH7ECapOddMDifNuSbKczfbItAmtGt8usJkVxZA4-yB73GAI8P8TR7f766WV7kl29fv1k2l7nhUrK872kNmnd12XadLupCQ0XbihqWnqHVrOe9qOvWaNMKkJrLSstWcqEXkJiqOM1e7HXHqd1BZ2CIXqMavd1pf6ectur_ymC36pP7piouFmmJSeDZQcC7NG-IamfTUIh6ADcFxRYlk3XNSp7Qp__2-tvkz84TIPbArcMIPnzB6Ra82oLGuFWMqtlcdTB3TtTe3OI3XIGaYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1841799142</pqid></control><display><type>article</type><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</creator><creatorcontrib>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</creatorcontrib><description>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis. APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.116.308561</identifier><identifier>PMID: 27856454</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Animals ; Aorta, Thoracic - drug effects ; Aorta, Thoracic - metabolism ; Aorta, Thoracic - pathology ; Aorta, Thoracic - physiopathology ; Aortic Diseases - genetics ; Aortic Diseases - metabolism ; Aortic Diseases - pathology ; Aortic Diseases - prevention &amp; control ; Apolipoproteins E - deficiency ; Apolipoproteins E - genetics ; Atherosclerosis - genetics ; Atherosclerosis - metabolism ; Atherosclerosis - pathology ; Atherosclerosis - prevention &amp; control ; Cell Movement ; Cells, Cultured ; Collagen - metabolism ; Disease Models, Animal ; Disease Progression ; Endothelial Cells - drug effects ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Fibrosis ; Macrophages - metabolism ; Macrophages - pathology ; Male ; Matrix Metalloproteinase 2 - metabolism ; Mice, Inbred C57BL ; Mice, Knockout ; Muscle, Smooth, Vascular - metabolism ; Muscle, Smooth, Vascular - pathology ; Muscle, Smooth, Vascular - physiopathology ; Myocytes, Smooth Muscle - metabolism ; Myocytes, Smooth Muscle - pathology ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type III - metabolism ; Plaque, Atherosclerotic ; Purinergic P2Y Receptor Agonists - pharmacology ; Receptors, Purinergic P2Y2 - deficiency ; Receptors, Purinergic P2Y2 - genetics ; Rupture, Spontaneous ; Signal Transduction ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83</ispartof><rights>2017 American Heart Association, Inc.</rights><rights>2016 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27856454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Xingjuan</creatorcontrib><creatorcontrib>Qian, Shaomin</creatorcontrib><creatorcontrib>Hoggatt, April</creatorcontrib><creatorcontrib>Tang, Hongying</creatorcontrib><creatorcontrib>Hacker, Timothy A</creatorcontrib><creatorcontrib>Obukhov, Alexander G</creatorcontrib><creatorcontrib>Herring, Paul B</creatorcontrib><creatorcontrib>Seye, Cheikh I</creatorcontrib><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis. APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</description><subject>Animals</subject><subject>Aorta, Thoracic - drug effects</subject><subject>Aorta, Thoracic - metabolism</subject><subject>Aorta, Thoracic - pathology</subject><subject>Aorta, Thoracic - physiopathology</subject><subject>Aortic Diseases - genetics</subject><subject>Aortic Diseases - metabolism</subject><subject>Aortic Diseases - pathology</subject><subject>Aortic Diseases - prevention &amp; control</subject><subject>Apolipoproteins E - deficiency</subject><subject>Apolipoproteins E - genetics</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - metabolism</subject><subject>Atherosclerosis - pathology</subject><subject>Atherosclerosis - prevention &amp; control</subject><subject>Cell Movement</subject><subject>Cells, Cultured</subject><subject>Collagen - metabolism</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Endothelial Cells - drug effects</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Fibrosis</subject><subject>Macrophages - metabolism</subject><subject>Macrophages - pathology</subject><subject>Male</subject><subject>Matrix Metalloproteinase 2 - metabolism</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Muscle, Smooth, Vascular - metabolism</subject><subject>Muscle, Smooth, Vascular - pathology</subject><subject>Muscle, Smooth, Vascular - physiopathology</subject><subject>Myocytes, Smooth Muscle - metabolism</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type III - metabolism</subject><subject>Plaque, Atherosclerotic</subject><subject>Purinergic P2Y Receptor Agonists - pharmacology</subject><subject>Receptors, Purinergic P2Y2 - deficiency</subject><subject>Receptors, Purinergic P2Y2 - genetics</subject><subject>Rupture, Spontaneous</subject><subject>Signal Transduction</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc9u1DAQxiMEon_gBTggH7mk2E5iby5IYdlSpLas2ILEyXKcCWuYjYPtUPWAxDvwhjwJjnZBcPF4PD9_o5kvy54wesaYYM-bmw8vm4tmTs4KuqgEu5cds4qXeSkKcT_dqazzSpT8KDsJ4TOltOScPsyOuEx0WZXH2ffV0Lm4BbQayRIQf_34uRnB2N4a8goQonUDcT1Z84-cvAMDY3SerL3buQiBrFF_nYBsom4t2nhH7ECapOddMDifNuSbKczfbItAmtGt8usJkVxZA4-yB73GAI8P8TR7f766WV7kl29fv1k2l7nhUrK872kNmnd12XadLupCQ0XbihqWnqHVrOe9qOvWaNMKkJrLSstWcqEXkJiqOM1e7HXHqd1BZ2CIXqMavd1pf6ectur_ymC36pP7piouFmmJSeDZQcC7NG-IamfTUIh6ADcFxRYlk3XNSp7Qp__2-tvkz84TIPbArcMIPnzB6Ra82oLGuFWMqtlcdTB3TtTe3OI3XIGaYg</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Chen, Xingjuan</creator><creator>Qian, Shaomin</creator><creator>Hoggatt, April</creator><creator>Tang, Hongying</creator><creator>Hacker, Timothy A</creator><creator>Obukhov, Alexander G</creator><creator>Herring, Paul B</creator><creator>Seye, Cheikh I</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201701</creationdate><title>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</title><author>Chen, Xingjuan ; Qian, Shaomin ; Hoggatt, April ; Tang, Hongying ; Hacker, Timothy A ; Obukhov, Alexander G ; Herring, Paul B ; Seye, Cheikh I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2771-ff09ea2d94bdda393ae50b50c19eaeba1f2f699bcacb6e7a275a7b726a8ec1953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Aorta, Thoracic - drug effects</topic><topic>Aorta, Thoracic - metabolism</topic><topic>Aorta, Thoracic - pathology</topic><topic>Aorta, Thoracic - physiopathology</topic><topic>Aortic Diseases - genetics</topic><topic>Aortic Diseases - metabolism</topic><topic>Aortic Diseases - pathology</topic><topic>Aortic Diseases - prevention &amp; control</topic><topic>Apolipoproteins E - deficiency</topic><topic>Apolipoproteins E - genetics</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - metabolism</topic><topic>Atherosclerosis - pathology</topic><topic>Atherosclerosis - prevention &amp; control</topic><topic>Cell Movement</topic><topic>Cells, Cultured</topic><topic>Collagen - metabolism</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Endothelial Cells - drug effects</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Fibrosis</topic><topic>Macrophages - metabolism</topic><topic>Macrophages - pathology</topic><topic>Male</topic><topic>Matrix Metalloproteinase 2 - metabolism</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Muscle, Smooth, Vascular - metabolism</topic><topic>Muscle, Smooth, Vascular - pathology</topic><topic>Muscle, Smooth, Vascular - physiopathology</topic><topic>Myocytes, Smooth Muscle - metabolism</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type III - metabolism</topic><topic>Plaque, Atherosclerotic</topic><topic>Purinergic P2Y Receptor Agonists - pharmacology</topic><topic>Receptors, Purinergic P2Y2 - deficiency</topic><topic>Receptors, Purinergic P2Y2 - genetics</topic><topic>Rupture, Spontaneous</topic><topic>Signal Transduction</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xingjuan</creatorcontrib><creatorcontrib>Qian, Shaomin</creatorcontrib><creatorcontrib>Hoggatt, April</creatorcontrib><creatorcontrib>Tang, Hongying</creatorcontrib><creatorcontrib>Hacker, Timothy A</creatorcontrib><creatorcontrib>Obukhov, Alexander G</creatorcontrib><creatorcontrib>Herring, Paul B</creatorcontrib><creatorcontrib>Seye, Cheikh I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xingjuan</au><au>Qian, Shaomin</au><au>Hoggatt, April</au><au>Tang, Hongying</au><au>Hacker, Timothy A</au><au>Obukhov, Alexander G</au><au>Herring, Paul B</au><au>Seye, Cheikh I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2017-01</date><risdate>2017</risdate><volume>37</volume><issue>1</issue><spage>75</spage><epage>83</epage><pages>75-83</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><abstract>OBJECTIVE—Nucleotide P2Y2 receptor (P2Y2R) contributes to vascular inflammation by increasing vascular cell adhesion molecule-1 expression in endothelial cells (EC), and global P2Y2R deficiency prevents fatty streak formation in apolipoprotein E null (ApoE) mice. Because P2Y2R is ubiquitously expressed in vascular cells, we investigated the contribution of endothelial P2Y2R in the pathogenesis of atherosclerosis. APPROACH AND RESULTS—EC-specific P2Y2R-deficient mice were generated by breeding VEcadherin5-Cre mice with the P2Y2R floxed mice. Endothelial P2Y2R deficiency reduced endothelial nitric oxide synthase activity and significantly altered ATP- and UTP (uridine 5’-triphosphate)-induced vasorelaxation without affecting vasodilatory responses to acetylcholine. Telemetric blood pressure and echocardiography measurements indicated that EC-specific P2Y2R-deficient mice did not develop hypertension. We investigated the role of endothelial P2Y2R in the development of atherosclerotic lesions by crossing the EC-specific P2Y2R knockout mice onto an ApoE background and evaluated lesion development after feeding a standard chow diet for 25 weeks. Histopathologic examination demonstrated reduced atherosclerotic lesions in the aortic sinus and entire aorta, decreased macrophage infiltration, and increased smooth muscle cell and collagen content, leading to the formation of a subendothelial fibrous cap in EC-specific P2Y2R-deficient ApoE mice. Expression and proteolytic activity of matrix metalloproteinase-2 was significantly reduced in atherosclerotic lesions from EC-specific P2Y2R-deficient ApoE mice. Furthermore, EC-specific P2Y2R deficiency inhibited nitric oxide production, leading to significant increase in smooth muscle cell migration out of aortic explants. CONCLUSIONS—EC-specific P2Y2R deficiency reduces atherosclerotic burden and promotes plaque stability in ApoE mice through impaired macrophage infiltration acting together with reduced matrix metalloproteinase-2 activity and increased smooth muscle cell migration.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>27856454</pmid><doi>10.1161/ATVBAHA.116.308561</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 2017-01, Vol.37 (1), p.75-83
issn 1079-5642
1524-4636
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5268079
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Animals
Aorta, Thoracic - drug effects
Aorta, Thoracic - metabolism
Aorta, Thoracic - pathology
Aorta, Thoracic - physiopathology
Aortic Diseases - genetics
Aortic Diseases - metabolism
Aortic Diseases - pathology
Aortic Diseases - prevention & control
Apolipoproteins E - deficiency
Apolipoproteins E - genetics
Atherosclerosis - genetics
Atherosclerosis - metabolism
Atherosclerosis - pathology
Atherosclerosis - prevention & control
Cell Movement
Cells, Cultured
Collagen - metabolism
Disease Models, Animal
Disease Progression
Endothelial Cells - drug effects
Endothelial Cells - metabolism
Endothelial Cells - pathology
Fibrosis
Macrophages - metabolism
Macrophages - pathology
Male
Matrix Metalloproteinase 2 - metabolism
Mice, Inbred C57BL
Mice, Knockout
Muscle, Smooth, Vascular - metabolism
Muscle, Smooth, Vascular - pathology
Muscle, Smooth, Vascular - physiopathology
Myocytes, Smooth Muscle - metabolism
Myocytes, Smooth Muscle - pathology
Nitric Oxide - metabolism
Nitric Oxide Synthase Type III - metabolism
Plaque, Atherosclerotic
Purinergic P2Y Receptor Agonists - pharmacology
Receptors, Purinergic P2Y2 - deficiency
Receptors, Purinergic P2Y2 - genetics
Rupture, Spontaneous
Signal Transduction
Vasodilation - drug effects
Vasodilator Agents - pharmacology
title Endothelial Cell–Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A16%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20Cell%E2%80%93Specific%20Deletion%20of%20P2Y2%20Receptor%20Promotes%20Plaque%20Stability%20in%20Atherosclerosis-Susceptible%20ApoE-Null%20Mice&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Chen,%20Xingjuan&rft.date=2017-01&rft.volume=37&rft.issue=1&rft.spage=75&rft.epage=83&rft.pages=75-83&rft.issn=1079-5642&rft.eissn=1524-4636&rft_id=info:doi/10.1161/ATVBAHA.116.308561&rft_dat=%3Cproquest_pubme%3E1841799142%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1841799142&rft_id=info:pmid/27856454&rfr_iscdi=true